A private hospital has been praised for its success at wiping out infections.
The rigorous hygiene regime at Spire Yale Hospital in Wrexham has enabled them to maintain high infection control standards.
The latest figures revealed hospital acquired infections like MRSA and CDiff showed a rate of zero per cent.
The news was revealed to North Wales AM Aled Roberts during a visit to the hospital.
The 27-bed hospital, which celebrated its 25th anniversary last year and is part of the Spire Healthcare group, carries out 2,000 operations a year.
The hospital, which employs 115 people, is investing £500,000 in new state-of-the-art equipment in 2014.
Spire Yale is upgrading its facilities at a time when they are experiencing growing demand from self-paying patients.
As part of the investment programme, a new £130,000 laminar flow clean-air system has just been installed in one of the hospital’s two main operating theatres.
There are also plans for new lasers for the urology department and a new microscope costing £40,000 for ophthalmic and spinal work in the operating theatre.
Meanwhile, £300,000 has been set aside for new x-ray equipment which should arrive later this year.
Mr Roberts said: “Clearly, the owners have a continued commitment to invest here in Wrexham.
“They have a very good record in relation to infection control. The fact that they have individual rooms for patients means that more effective barriers against the transmission of infection can be created.
“Clearly we know about the pressures elsewhere as far as occupancy rates are concerned but credit where credit is due, their infection control figures are very impressive.”
Hospital Manager Sue Jones was delighted Mr Roberts had taken the time and the trouble to come on a guided tour of the hospital and meet the staff.
She said: “We thoroughly enjoyed having him here and we were able to tell him a number of things about the investment that’s happening locally and across all Spire hospitals.
“Spire Healthcare are a national company with almost 40 hospitals in the group and they believe in reinvesting into their hospitals. Locally we’ve been allocated close to £500,000 in 2014.
“We’re very proud of our record on hospital acquired infections. The 2013 outcome statistics for MRSA bacteraemia and C Diff for Spire Yale showed a rate of zero per cent.
“We have a very high level of infection control at the hospital but there is no room for complacency. We are very vigilant because it’s about making sure that everything that needs to be done is done to make sure we maintain our high record.
“It’s a very important issue and when patients come into hospital it’s one of the first questions they ask.
“It used to be all about waiting lists and finance but now one of the key questions is about the infection rates within the hospital.
“It can have a really bad effect on the outcomes of surgery so it is a paramount priority is to make sure that everything is spot on.
“To that end we have just spent £130,000 on installing a new laminar flow clean air system in one of the operating theatres.
“Our aim at Spire is to be world class and to do that you’ve got to invest in the business to ensure the best possible treatment for our patients.”
